4-[5-(4,4,5,5-Tetramethyl-[1,3,2]Dioxaborolan-2-Yl)-Pyridin-2-Yl]-Piperazine-1-Carboxylic Acid Tert-Butyl Ester: Reliability Built From the Reactor Up

Opening Doors for Modern Chemistry

In our years at the bench and on the plant floor, few compounds have symbolized progress in medicinal chemistry the way boronic esters have. Today, 4-[5-(4,4,5,5-Tetramethyl-[1,3,2]Dioxaborolan-2-Yl)-Pyridin-2-Yl]-Piperazine-1-Carboxylic Acid Tert-Butyl Ester stands as a prime example of careful design meeting practical needs. We’ve seen demand grow steadily in the last decade for heterocyclic boronates, driven by pharmaceutical research teams looking to build new connections on pyridine scaffolds. Serving researchers in North America, Europe, and Asia, we remain focused on optimizing both scale-up and overall value delivery—because the right starting material cuts hours, not just costs.

We engineer this product to fit directly into complex Suzuki-Miyaura cross-coupling reactions. Medicinal chemistry depends on functional groups holding their own through dozens of steps; the boronic ester here brings both reactivity and stability to the table. The tert-butyl protected piperazine allows a tack at selectivity that plain piperazines won’t offer, while the pyridinyl group means structure-activity relationship studies keep moving with minimal synthetic detour.

Direct Sourcing, Real Consistency

We don’t think in terms of catalog numbers. We think in terms of batches: mosaic patterns of white powders and off-white granules, the tang of dry solvents in the air, the hum of the vacuum pump. Consistency comes not from chance, but from process validation, in-line monitoring, and operators who know their craft. Customers asked for cleaner NMR spectra, lower metallic impurities, and reliable lot-to-lot performance. Over the years, in response, we invested in precision weighing, inert-atmosphere workups, and in-house analytical tools—high-resolution LC-MS, NMR, and ICP-OES—so what leaves our warehouse measures up where it counts, every time.

Take it from the benches where our own chemists work: instability during Suzuki couplings does not just reduce yield, it stalls the whole project. This boronic ester holds up in standard solvents, tolerates a range of base/ligand systems, and resists hydrolysis during basic aqueous workups far better than earlier-generation analogues. We see fewer side reactions and cleaner separations—an advantage only clear after you’ve run the same transformation enough times to really appreciate what impurities do to downstream steps.

Key Physical and Chemical Properties

At our scale, reproducibility is king. We produce this compound with special attention to its melting and decomposition points, packing, and hygroscopicity. Our batches offer consistent purity as determined by HPLC and NMR (both 1H and 13C, plus 11B where necessary), with boron content tightly controlled through ICP-OES. Small-scale users and kilo-lab scale managers alike have told us bulk density and flowability make a bigger difference than they expected; we tailor our crystallization and drying to make it easy to handle from the first gram up to the first ten kilos.

The tert-butyl group on the piperazine enables selective Boc-deprotection at later stages. It becomes a targeting handle: chemists use it to steer orthogonality in protecting group strategies, minimizing rework and maximizing throughput in multistep campaigns. The dioxaborolane ring, known for excellent shelf stability, allows stockroom storage for longer cycles, reducing the headache of overnight inventories or last-minute rush orders.

Why This Compound Suits Advanced Synthesis

What sets this boronic ester apart is its utility for sp²-sp² carbon coupling, especially where harsh conditions destroy more sensitive motifs. We have seen bench chemists benefit from the relatively straightforward purification profiles after cross-coupling; this means less time tweaking chromatography, fewer unexpected byproducts, and more confidence setting up late-stage functionalization. The clean separation of both organic solvents and water brings a practical edge, especially in medicinal chemistry teams juggling many parallel syntheses.

Our plant team learned quickly: impurities introduced here show up again and again in late-phase purification. To that end, we go heavy on quality control at the point of dioxaborolane ring formation, and we audit the piperazine input for trace amines and related compounds. This would matter less in simpler molecules, but the sensitivity of drug-like intermediates means every part per million counts in saving time and boosting final yields.

Differentiation From Other Boronic Esters

The historic challenge with pyridinyl boronic esters has always been stability versus reactivity. Unprotected piperazines decompose under basic workup or in prolonged extractions. Our version, with Boc-piperazine, bridges this gap: it tolerates most stockroom conditions, remains bench-stable for months, and delivers clean transformation under established Suzuki conditions. You won’t see as much hydrolysis or mis-coupling—two headaches our customers cited when switching away from bromo- and iodo-pyridines.

Compared to methyl, ethyl, or even neopentyl-based dioxaborolanes, the 4,4,5,5-tetramethyl configuration strikes the best balance between shelf-life and coupling activity. Too few methyls, you lose hydrolytic resistance; too many, purification slows to a crawl. We’ve lived the difference on kilo-lab and production floors, especially scaling up pilot projects for contract research and new drug launches. These practical lessons—lost yields, clogged columns, wasted solvents—shape the product we ship every week.

Application in Drug Discovery and Pharmaceuticals

Pharmaceutical research teams often take feedback from downstream partners—biologists, toxicologists, regulatory experts—and trace issues in library design back to one or two unreliable building blocks. This boronic ester shows up time and again in kinase inhibitor programs, GPCR ligands, and CNS-active scaffolds. We’ve seen clinical candidates progress from paper to first-in-human trials, using our pyridinyl boronic ester as a coupling partner in pivotal steps.

What matters most here is suppressed impurity profiles. Our in-process testing minimizes transition-metal traces (Pd, Cu, Ni), which, at these steps, pose headaches during purification and, eventually, during closure of regulatory documentation. Feedback from small pharma labs to large established players led us to incrementally refine our protocols—quenching, aqueous workup, and solid-state handling—so every lot meets ICH and regional agency standards without significant additional cleanup on the customer’s side.

In fragment-based drug design, the unit plays a modular role. Researchers can modify the piperazine, swap out protecting groups, or elaborate the pyridine ring with minimal reoptimization. This saves medicinal chemistry programs time in lead expansion and candidate selection, as SAR exploration proceeds in parallel and not in series. Success belongs to teams able to run parallel chemistry reliably, and this compound fits into that scheme—right down to how it weighs and dissolves on automated platforms.

Sustainability and Process Safety

Long gone are the days when chemical manufacturers could ignore solvent usage, energy input, or operator safety. We build our boronic esters under inert gas with robust control at every temperature ramp, and our solvent recovery rate entered above 80% this past year, a solid improvement driven by process redesign.

Safety walks hand-in-hand with quality. Piperazine intermediates benefit from real-time monitoring for peroxide formation or unstable amine byproducts. By refining quenching sequences and solvent ratios, we achieved lower waste generation per kilo of product—this matters for both cost and regulatory reporting. Of note: every kilogram of 4-[5-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-pyridin-2-yl]-piperazine-1-carboxylic acid tert-butyl ester we ship has its production batch traceable down to the operators working the distillation and the QA team responsible for sampling. Every operator has skin in the game, and every lab downstream benefits from their attention.

Scaling Without Compromise

Early pilot runs tested both the patience and problem-solving of our process team. Maintaining high purity and performance across batches—from a few grams to multi-kilo runs—brought hard lessons. We invested in jacketed reactors, improved agitation, and automated dosing. Yield improvements came not only from optimizing reaction parameters, but also from streamlining downstream workups and crystallization. The time spent optimizing these details is invisible on a data sheet but visible in delivery schedules and downstream results.

Routine doesn’t mean simple. Boronic esters like this one benefit from precise environmental controls—think dew point management, nitrogen purity, and cleanroom policies—especially at scale. Our production staff receives regular hazard and cGMP training. The lessons learned from scaling up have contributed to safer, more predictable operations with few surprises at ship deadline. If a customer is testing gram samples for a medicinal chemistry campaign, or looking to ramp up to kilograms for clinical supply, the same tight controls apply, because no one wants variability sneaking into the process when so much rides on each batch.

Edge Cases and Problem Solving

Every now and then, industrial synthetic chemistry throws a curveball. Customers report stubborn carry-over of residual boronic acid, or color formation in pilot batches. We trace these to process drift or aged reagents at source, and every batch is requalified by running standard Suzuki reactions. Years at the lab bench taught us the value of “fail fast”—troubleshooting with real-life conditions, not just theoretical models.

Another regular concern involves packaging and logistics. Sensitive boronic esters degrade faster in standard polyethylene vessels. Our move to lined containers and humidity-indicator desiccants came from seeing real losses in the field, shipments delayed due to partial decomposition. We monitor storage environments during transport, aiming to help customers move through their product steady and without sudden surprises on the day of use. Every lot is packed with shipment route and destination climate in mind.

Shelf-life questions keep coming up, especially for teams needing product over many months for SAR campaigns. Our plant achieves up to 18-month stability under inert gas and desiccation; we offer guidance for repacking, partial usage, or long-term freezing. These are details that help chemistry teams focus on the science, not worrying over bottlenecks caused by raw material stability.

Responding to Market Needs

Requests for customized packing, alternative QC protocols, or modified specifications go beyond the norm in this industry. Still, the value in listening is clear: we’ve run alternate purifications to satisfy high-sensitivity NMR demands or supplied documentation for custom analytical methods. One customer needed pre-measured aliquots for direct transfer into robotic screening platforms; another asked for special data packages tracking residual elemental impurities across lots. By connecting the end-user’s workflow back to our production plant, we close the feedback loop and refine both chemistry and service.

No two markets are alike. Academic labs demand small packs, while pharmaceutical process teams ask about multi-kilo drum deliveries—each comes with different risk profiles and logistical requirements. By working direct, with no intermediaries, we adapt quickly to last-minute shifts in project scale or regulatory changes. Over time, these direct lines have built long-term trust that outlasts any given order cycle.

Learning from Industry Benchmarks

Looking around the industry, we see other boronic esters entering the market with promises of price or speed. From our vantage point, real value means building for practicality, not just lowest cost. Recalls or delays drag programs years behind. For us, that means calibrating instruments regularly, running real cross-coupling tests with each lot, and holding operators accountable to the same standards chemists run at the bench.

As customers adopt ever-more-sophisticated automation, robust reference materials become more critical. Our process accommodates the need for automated weighing, high-throughput screening, and robotic liquid handling. This isn’t just future-proofing for the lab, but adapting chemistry to evolving business and research needs. By investing continually in our people and infrastructure, we ensure that the material you receive today holds up to both legacy protocols and next-generation workflows.

Real Experience Driving Real Results

Teams on both sides of the production-transformation divide—chemists looking to build new molecules and our operators ensuring fast, well-characterized shipments—understand the stakes. Bad product makes for bad data; good material sets up a clear workflow from the very first reaction. We don’t chase trends or cut corners; feedback from the field shapes every choice in the production and logistics chain. We judge our success by the repeat business and sabbatical calls from customers moving onto new projects and new challenges.

Year after year, medicinal and process chemists come back to this compound for its dependability. Whether aiming for a new scaffold, scaling up to support a clinical candidate, or mapping out a new library, our boronic ester keeps pace with the demands of leading-edge drug discovery. That track record—built batch by batch, shipment by shipment—reflects the experience and dedication behind the product, and the results speak for themselves in the labs where discovery happens.